|
Brainlabs B.V. focuses on the development, and commercialization of molecular diagnostics for psychiatric and mental diseases. The company is privately owned and has a vast experience in diagnostics and psychiatry. Brainlabs collaborates with clinical and academic centers in the Netherlands to develop biomarkers for Major depression and Alzheimer.
The company serves the R&D market for Alzheimer, Major depression and neuroscience related products in the Netherlands.. Its place of business is Enschede, the Netherlands.
|
